Prognostic impact of osteosarcopenia on postoperative outcomes in patients with biliary tract cancer

  • 0Department of Hepatobiliary and Pancreatic Surgery, NHO Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan. rgwsn6911@gmail.com.

|

|

Summary

This summary is machine-generated.

Osteosarcopenia, the combination of sarcopenia and osteopenia, predicts poor survival in patients undergoing biliary tract cancer resection. This finding highlights osteosarcopenia as a crucial prognostic factor for adverse outcomes post-surgery.

Area Of Science

  • Oncology
  • Geriatrics
  • Radiology

Background

  • Frailty, encompassing sarcopenia and osteopenia, is linked to reduced survival in biliary tract cancer (BTC) patients post-resection.
  • Osteosarcopenia, the concurrent presence of sarcopenia and osteopenia, has emerged as a predictor of poor outcomes in various cancer types.

Purpose Of The Study

  • To evaluate the prognostic significance of osteosarcopenia in patients who have undergone resection for biliary tract cancer.
  • To determine if osteosarcopenia is an independent predictor of survival after BTC surgery.

Main Methods

  • A cohort of 109 patients who underwent BTC resection between 2014 and 2021 were analyzed.
  • Sarcopenia was assessed via psoas muscle computed tomography, and osteopenia via bone mineral density measurements.
  • Osteosarcopenia was defined as the simultaneous presence of both sarcopenia and osteopenia.

Main Results

  • The study found sarcopenia in 50% of patients, osteopenia in 46%, and osteosarcopenia in 28%.
  • Osteosarcopenia was associated with a higher incidence of lymph node metastasis.
  • Multivariate analysis identified osteosarcopenia, lymph node metastasis, and poor tumor differentiation as independent predictors of poor disease-free survival.

Conclusions

  • Osteosarcopenia is a significant prognostic factor for unfavorable outcomes following biliary tract cancer resection.
  • The presence of osteosarcopenia independently predicts poor disease-free and overall survival in BTC patients.